Mohanakumar T, Coffey T W, Vaughn M P, Russell E C, Conrad D
Blood. 1983 Jan;61(1):66-70.
A non-human primate antiserum was prepared to acute lymphoblastic leukemia of T-cell phenotype (T-ALL) and, after absorptions with normal blood elements, reacted by immunofluorescence and microcytotoxicity to all the T-ALL tested. In addition, the antiserum reacted with cells from about 70% of the common ALL studied and immunoprecipitated the common ALL antigen of 100,000 daltons. However, when the anti-T-ALL serum was absorbed with with lymphoblasts from common ALL, it failed to react with common ALL lymphoblasts, yet reacted significantly with cells from patients with T-ALL phenotype and defined a 100,000-dalton membrane component not found on common ALL lymphoblasts. In addition, sequential immunoprecipitation of 125I-labeled T-ALL membranes by anti-common-ALL serum followed by anti-T-ALL serum detected the T-ALL membrane component of 100,000 daltons that was not found on common ALL. Thus, our results demonstrate the presence of of a unique human T-ALL antigen present on all T-ALL distinct from the common ALL antigen.
制备了针对T细胞表型急性淋巴细胞白血病(T-ALL)的非人灵长类动物抗血清,在用正常血液成分吸收后,通过免疫荧光和微量细胞毒性反应与所有测试的T-ALL发生反应。此外,该抗血清与约70%研究的普通ALL细胞发生反应,并免疫沉淀出100,000道尔顿的普通ALL抗原。然而,当抗T-ALL血清用普通ALL的淋巴母细胞吸收后,它不再与普通ALL淋巴母细胞发生反应,但与T-ALL表型患者的细胞仍有显著反应,并确定了一种在普通ALL淋巴母细胞上未发现的100,000道尔顿的膜成分。此外,先用抗普通ALL血清对125I标记的T-ALL膜进行连续免疫沉淀,然后用抗T-ALL血清进行免疫沉淀,检测到普通ALL上未发现的100,000道尔顿的T-ALL膜成分。因此,我们的结果表明,在所有T-ALL上存在一种独特的人类T-ALL抗原,它不同于普通ALL抗原。